Biosimilar Market in Europe

The biosimilar market in Europe is projected to reach US$ 53,222.9 million by 2032, exhibiting a CAGR of 17.6%, according to Imarcgroup.com.

  • Viesearch
    Moderated and indexed this listing ·
  • samwalter's profile picture
    @samwaltereditor
    Submitted this listing ·

Editorial Actions

Feature Edit